|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-9-27
|
|
pubmed:abstractText |
To review the main findings of the Euralox 1 study - a multicentre, randomised, double-blind study conducted in 1008 healthy postmenopausal women allocated to raloxifene (n = 495) or continuous combined estrogen-progestin therapy (ccEPT; n = 513) for 6 months -- and provide an overview of the risks and benefits of raloxifene and ccEPT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0378-5122
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
16
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
87-101
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15967604-Bone Remodeling,
pubmed-meshheading:15967604-Drug Combinations,
pubmed-meshheading:15967604-Endometrium,
pubmed-meshheading:15967604-Estradiol,
pubmed-meshheading:15967604-Female,
pubmed-meshheading:15967604-Fibrinogen,
pubmed-meshheading:15967604-Humans,
pubmed-meshheading:15967604-Lipids,
pubmed-meshheading:15967604-Middle Aged,
pubmed-meshheading:15967604-Multicenter Studies as Topic,
pubmed-meshheading:15967604-Postmenopause,
pubmed-meshheading:15967604-Progestins,
pubmed-meshheading:15967604-Raloxifene,
pubmed-meshheading:15967604-Randomized Controlled Trials as Topic,
pubmed-meshheading:15967604-Selective Estrogen Receptor Modulators
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox 1.
|
|
pubmed:affiliation |
Department of Gynaecological Oncology and Multidisciplinary Breast Centre, UZ-Gasthuisberg, Leuven, Belgium. patrick.neven@zu.kuleuven.ac.be
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review
|
